Full guide

Antibody identification from basics to complete panel strategy.

This page is the deeper reference. It covers the blood bank basics, antibody classes, clinically significant systems, phases, dosage, enzyme effects, autocontrol and DAT interpretation, and the practical steps used to work through a blood bank antibody identification case.

Go to practice Back to quick start

Core topics

Blood bank basics before opening a panel.

Antibody identification compares a patient's serum or plasma with reagent red cells that have known antigen profiles. The goal is to identify likely antibody specificity, decide whether it is clinically significant, and select compatible donor blood if needed.

Red cell antigens and antibodies

A panel works by matching patient serum or plasma against reagent red cells with known antigen profiles. The question is which antibody explains the reaction pattern.

IAT vs DAT

The indirect antiglobulin test detects free antibody in serum or plasma. The direct antiglobulin test detects IgG or complement already coating red cells in vivo.

Alloantibody vs autoantibody

A negative autocontrol supports alloantibody. A positive autocontrol or DAT raises concern for autoantibody, recent transfusion, or another mixed picture.

Clinical significance

Rh, Kell, Duffy, and Kidd are commonly cited clinically significant systems because they can shorten red cell survival or cause HDFN.

Clinical significance

Which antibodies matter and why.

Clinically significant antibodies are the ones that can shorten red cell survival or cause hemolytic disease of the fetus and newborn. In many routine workups, that means looking for antibodies that react at 37 C and/or AHG.

Usually important

Rh, Kell, Duffy, and Kidd are common high-yield systems.

Usually less important

Lewis antibodies are often colder and less clinically significant, though some exceptions are clinically important.

Reaction phases

What each phase is telling you.

Phase	Meaning	How to think about it
Immediate spin	Often points toward cold-reactive antibodies such as ABO-type or Lewis patterns.	If reactivity is only here, think colder and usually less clinically significant.
37 C	Suggests a warmer thermal range and raises concern for clinically significant IgG.	This phase matters when you are deciding whether an antibody could cause harm.
AHG	Detects IgG-sensitized red cells that do not visibly agglutinate on their own.	Strong AHG reactivity is a major clue that the antibody is clinically important.

Major systems

The systems you should recognize first.

Rh

High yield

Common, warm-reactive, and often dosage-sensitive.

Rh antibodies are a major cause of transfusion reactions and HDFN.

Kell

High yield

Highly immunogenic and usually clinically important.

Anti-K can cause transfusion reactions and HDFN even when the serology is not dramatic.

Duffy

High yield

Dosage-sensitive and enzyme-sensitive.

Anti-Fya and anti-Fyb are important because they can shorten red cell survival and matter in pregnancy.

Kidd

High yield

Weak, variable, and often delayed or evanescent.

Kidd antibodies are classic delayed transfusion reaction antibodies and are easy to miss.

Lewis

High yield

Often cold-reactive and usually less significant.

Lewis antibodies are commonly less concerning, but rare warm-reactive exceptions exist.

Pattern recognition

Common antibody behaviors worth memorizing.

Rh, Duffy, Kidd

Rh antibodies are often warm and may show dosage.
Duffy antibodies are dosage-sensitive and enzyme sensitive.
Kidd antibodies can be weak, variable, and delayed or evanescent.

Kell and Lewis

Kell antibodies are often strong and clinically important, but serology can vary.
Lewis antibodies are often colder and often less significant.
Rare Lewis antibodies can still matter if they react at 37 C.

Rule-out strategy

How nonreactive cells narrow the list.

Rule-out means using antigen-negative results to exclude antibodies you do not think are responsible for the pattern. If dosage is possible, homozygous cells matter because they are better at showing weak reactions.

Why homozygous cells matter

Some antibodies show dosage. A cell with two copies of an antigen may react more strongly than a heterozygous cell.

What a nonreactive cell tells you

If a cell does not react and it carries the antigen, the matching antibody becomes less likely. Use enough clean nonreactive cells to make the exclusion believable.

Rule-in and dosage

How to prove the best-fit antibody.

Rule of 3

One common teaching standard is to find at least 3 positive cells and 3 negative cells that support the antibody pattern. That increases confidence that the fit is real.

Dosage effect

Dosage means an antibody reacts more strongly with homozygous antigen expression than with heterozygous expression.

Autocontrol and DAT

Separating alloantibodies from autoantibodies.

Autocontrol

The autocontrol compares the patient's serum with the patient's own red cells. A negative result supports an alloantibody pattern.

DAT

The direct antiglobulin test looks for IgG and/or complement already attached to red cells in vivo. A positive result makes you think about autoantibody, hemolysis, HDFN, or recent transfusion.

Enzyme effects

What ficin and papain change.

Effect	Examples	Meaning
Often weakened or destroyed	Duffy, M, N	Enzyme treatment can remove useful target antigens from reagent cells.
Often enhanced	Rh, Kidd, Lewis, P1, I	Some antibodies become easier to see after ficin or papain treatment.
Variable	S and s	These can be affected inconsistently, so enzyme results should be interpreted carefully.
Unaffected	Kell	Kell antigens are generally not destroyed by ficin in this teaching model.
Why it matters	Pattern recognition	Enzymes can sharpen a pattern, but they can also erase helpful antigens.

Clinical context

History matters as much as the panel.

Ask about transfusion and pregnancy

Exposure from transfusion or pregnancy is a common reason a patient develops an alloantibody. It also helps explain why a previously negative patient now has a positive screen.

Think about hemolysis and recent events

A history of anemia, jaundice, hemolysis, recent transfusion, or suspected autoimmune disease changes how you interpret the workup.

Systematic approach

A practical order for working an antibody ID.

Check the phase and reaction strength.
Review autocontrol and DAT.
Look for a pattern that matches a known antibody system.
Rule out antibodies using nonreactive cells.
Pay attention to dosage and homozygous cells.
Rule in the best-fit antibody with positive and negative cells.
Confirm with phenotype, history, enzyme behavior, or additional studies.

Glossary

The terms a new user needs to recognize quickly.

Term	Meaning
Alloantibody	An antibody made against a foreign red cell antigen, often after transfusion or pregnancy.
Autoantibody	An antibody that reacts with the patient's own red cells.
Autocontrol	The patient's serum tested against the patient's own red cells.
DAT	The test that looks for antibody or complement already coating red cells in vivo.
IAT	The test that looks for free antibody in serum or plasma using reagent cells in vitro.
Dosage	A stronger reaction when antigen is expressed in double dose rather than single dose.
Clinically significant antibody	An antibody likely to cause transfusion reactions or hemolytic disease of the fetus and newborn.

Open access references

Sources used for this study guide.

Next step

Use the full guide when you want the complete picture, then practice.

The quick start page gives the essentials. This page gives the detailed version. The practice page turns both into panel work.

Go to practice Back to quick start